Hetenyi et al. had already showed that AutoDock can be used to perform docking of peptides to their targets, without a priori knowledge of the location of the binding site. Now, they have shown that AutoDock can be used for drug-sized molecules (Hetenyi and van det Spoel (2006) "Blind docking of drug-sized compounds to proteins with up to a thousand residues" FEBS Letters 580: 1447-1450). See also the FAQ, Can AutoDock be used for "Blind Docking"? for more examples of blind docking in the literature.